The small-cap penny stock market has been hot lately, with a surge in volume and activity across several names. The most in-play name, with price and volume soaring remarkably, has been T2 Biosystems ...

In 2014, Massachusetts-based T2 Biosystems (NASDAQ:TTOO) went public at $11 per share. Expectations were high for the young startup. Its sepsis-detecting products targeted a $20.3 billion industry, ...

T2 Biosystems (NASDAQ:TTOO) stock is the top-trending ticker on social media, and its shares are up over 30% today after the Food and Drug Administration (FDA) allowed the company to start marketing ...

Shares of T2 Biosystems (NASDAQ:TTOO) are up by over 20% today on the heels of receiving U.S. Food and Drug Administration (FDA) 510(k) clearance for its T2Biothreat Panel. The panel is a ...

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide ...

T2 Biosystems (NASDAQ:TTOO) shares closed 11% lower Wednesday, marking another rocky session for the diagnostics developer, which expressed doubts in its most recent 10-Q report about its ability to ...

With the rising prevalence of chronic diseases, consistent growth in the geriatric population, support from regulatory bodies, and the integration of digital technology, the medical device industry’s ...

T2 Biosystems (NASDAQ:TTOO) stock price scales 31% with the second largest sale of sepsis-driven T2Dx instruments in company history. Its distribution partner, Biomedica Poland, secured a multi-year ...